Unity Stock And 2 High Growth Picks Worth Watching Now

Inflation trends are front and centre again, with several major economies reporting mixed price data that keeps interest rate paths uncertain. When inflation and rates feel unpredictable, investors often look more closely at companies where analysts expect solid earnings growth and balance sheets that can absorb bumps in the cycle. This article highlights three stocks from the Healthy high growth potential screener that fit that profile and merit a closer look.

The three stocks highlighted below are only a small sample. The full screen surfaced 1,518 more companies with similarly compelling earnings and balance sheet profiles that are not covered here. To go straight to the source, use the Healthy high growth potential screener to filter, analyze, and identify the ideas that best fit your own approach.

Ardelyx (ARDX)

Overview: Ardelyx is a biopharmaceutical company that develops and sells prescription medicines for irritable bowel syndrome with constipation and chronic kidney disease, including IBSRELA and XPHOZAH, in the US and internationally.

Operations: Ardelyx currently generates about $450.9 million in revenue from the development and commercialization of its biopharmaceutical products.

Market Cap: $997 million

Ardelyx offers exposure to treatment demand for chronic kidney disease and gastrointestinal disorders through two commercial drugs that already generate meaningful product revenue. The company is still working to move from losses toward profitability. The stock sits at a low P/S multiple versus peers, and some analysts see room between the current price and their average target, but that gap depends on continued prescription trends and successful payer negotiations for IBSRELA and XPHOZAH. High cost debt, trimmed 2026 revenue guidance, and heavy reliance on a narrow product set mean execution risk is significant, which is why a closer look at Ardelyx may be important for patient investors.

Ardelyx sits at the crossroads of meaningful product revenue and a compressed P/S ratio that some investors may be overlooking. To see how that trade off compares with execution risk, review the 4 key rewards and 1 important warning sign

Build your own Ardelyx style screener

Ardelyx and the two other stocks in this list all came from a single Simply Wall St screener, which shows how powerful the right filters can be. Use our flexible Screener to blend metrics like valuation, earnings potential, balance sheet strength and risks, or start with one of our curated Investing Ideas for ready made shortlists.

Dutch Bros (BROS)

Overview: Dutch Bros is a US based coffee chain that runs and franchises drive thru shops, serving coffee, energy drinks, and related products under its Dutch Bros and Blue Rebel brands.

Operations: Dutch Bros generates about $1.74b from company operated shops and $141 million from franchising and other activities, all from the United States.

Market Cap: $10.0b

Investors watching Dutch Bros are seeing a fast growing drive thru coffee chain that is leaning into convenience, digital ordering, and a higher margin drink and food mix to lift revenue and earnings. This is supported by recent guidance for around $2.1b to $2.13b of 2026 revenue and Q2 revenue growth of 32% year on year. The company is pushing hard on new shop openings, acquisitions like Salad and Go sites, and an expanding food program. These initiatives could improve average ticket sizes but also raise execution and funding risk, especially with high leverage and a rich P/E. Strong earnings growth expectations and a bullish analyst consensus keep Dutch Bros firmly on the radar, yet the current valuation and reliance on aggressive expansion mean this is not a set and forget story.

Rapid new shop openings, 2026 revenue guidance around US$2.1b and a rich P/E put Dutch Bros at the centre of the growth versus valuation debate. The analyst forecasts for Dutch Bros could show whether that expansion story hides a sharper twist ahead

Unity Software (U)

Overview: Unity Software runs a platform that helps developers build, run, and grow games and interactive 2D and 3D experiences across mobile, PC, console, and extended reality devices. It is increasingly used by industries such as automotive, healthcare, and architecture.

Operations: Unity Software generates about $2.03b in revenue from its Computer Graphics segment, with sales spread across the United States, Greater China, EMEA, APAC, and other Americas.

Market Cap: $18.9b

Unity Software is attracting attention because it sits at the intersection of real time 3D creation, AI tools, and a growing advertising platform. The core Create and Grow solutions, along with the Vector ad platform, are central to analyst expectations for revenue growth of about 15% per year and a sharp swing from current losses toward profitability within 3 years. Q2 2026 results showed higher revenue, a much smaller loss, and guidance that brings GAAP profitability forward to Q3 2026. This has helped lift confidence in the turnaround. The trade off is high funding risk, a premium P/S, and recent insider selling, so the story may suit investors who are comfortable with execution and competition risks.

Unity Software sits at the crossroads of real time 3D, AI tools, and a growing ad platform, yet the key tension between revenue growth and funding risk is still easy to miss. The analyst forecasts for Unity Software hints at where that balance could quietly tilt next.

Seeking Fresh Alternatives Before Others?

Some of the sharpest breakouts start quietly while attention sits elsewhere. Use this window while it matters, before momentum is fully caught and prices stop dropping, and get in early.

• Hunt for potential turnarounds among 52 high quality undervalued stocks that combine solid cash flows with balance sheets built to handle shocks before the crowd fully catches on.
• Ride real economy momentum by scanning 37 power grid technology and infrastructure stocks supporting critical upgrades to transmission, distribution, and grid resilience while these opportunities remain under the radar for now.
• Target future facing automation by tracking 37 robotics and automation stocks that may benefit as robotics, warehousing, and industrial efficiency trends accelerate, so you are positioned before momentum really starts flying.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com